The School of Optometry and Vision Science is one of the professional schools at the University of Waterloo. It is a school within the university's Faculty of Science and is the larger of the two optometry schools in Canada.

During the past decade, University of Waterloo School of Optometry conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Waterloo School of Optometry" #1 sponsor was "Coopervision, Inc." with 3 trials, followed by "Shire" with 2 trials sponsored, "University of Waterloo" with 2 trials sponsored, "Azura Ophthalmics" with 1 trials sponsored and "Visioneering Technologies, Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Waterloo School of Optometry" #1 collaborator was "Bausch & Lomb Incorporated" with 1 trials as a collaborator, "Cliantha Research" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "Visioncare Research Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University of Waterloo School of Optometry" are "Myopia" (4 trials), "Dry Eye" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Healthy Controls" (1 trials). Many other conditions were trialed in "University of Waterloo School of Optometry" in a lesser frequency.

Most popular intervention types in "University of Waterloo School of Optometry" are "Device" (6 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PVP-I 0.6%" (2 trials), "Placebo" (2 trials), "SHP640" (2 trials), "delefilcon A" (2 trials) and "AZR-MD-001 High Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Waterloo School of Optometry" are 9 trials for "All" genders.

Currently, there are NaN active trials in "University of Waterloo School of Optometry". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Waterloo School of Optometry, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Waterloo School of Optometry, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".